Panel Discussion: How Can We Invigorate AKI Drug Development? Identifying Novel Targets & Establishing a Pathway to Surmount Challenges in Biomarkers & Precision Medicine
Time: 2:30 pm
day: Seminar Day
- What can we learn from clinical setbacks in AKI?
- Addressing translational barriers in AKI: optimizing models to predict efficacy and biomarkers of therapeutic target engagement
- Characterizing endophenotypes through omics approaches to enable comprehensive, longitudinal understanding of AKI